Literature DB >> 2574535

Prenatal diagnosis of Friedreich ataxia.

J Wallis1, J Shaw, D Wilkes, M Farrall, R Williamson, S Chamberlain, J C Skare, A Milunsky.   

Abstract

Friedreich ataxia is a progressive neurodegenerative disorder affecting the peripheral and central nervous systems. One in 50,000 of the population are affected by this recessively inherited disorder, with onset usually before puberty. The recent localization of the disease locus to chromosome 9 has made it possible to provide genetic counselling to families with at least one affected child. Tight linkage of the disease mutation to an anonymous DNA marker MCT112 (D9S15) has been shown with a pairwise lod score of 36.1 at 0 = 0. We report here the first prenatal diagnosis in Friedreich ataxia. Using MCT112 and the confidence interval approach, we have calculated risks for a fully informative family with one affected sib.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574535     DOI: 10.1002/ajmg.1320340327

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  8 in total

1.  Identification of a hypervariable microsatellite polymorphism within D9S15 tightly linked to Friedrich's ataxia.

Authors:  J Wallis; R Williamson; S Chamberlain
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

Review 2.  The DNA laboratory and neurological practice.

Authors:  A E Harding
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

Review 3.  Therapeutic strategies in Friedreich's ataxia.

Authors:  Timothy E Richardson; Heather N Kelly; Amanda E Yu; James W Simpkins
Journal:  Brain Res       Date:  2013-04-13       Impact factor: 3.252

4.  Estrogen prevents oxidative damage to the mitochondria in Friedreich's ataxia skin fibroblasts.

Authors:  Timothy E Richardson; Amanda E Yu; Yi Wen; Shao-Hua Yang; James W Simpkins
Journal:  PLoS One       Date:  2012-04-03       Impact factor: 3.240

5.  The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia.

Authors:  A Filla; G De Michele; F Cavalcanti; L Pianese; A Monticelli; G Campanella; S Cocozza
Journal:  Am J Hum Genet       Date:  1996-09       Impact factor: 11.025

6.  A Potential New Therapeutic Approach for Friedreich Ataxia: Induction of Frataxin Expression With TALE Proteins.

Authors:  Pierre Chapdelaine; Zoé Coulombe; Amina Chikh; Catherine Gérard; Jacques P Tremblay
Journal:  Mol Ther Nucleic Acids       Date:  2013-09-03       Impact factor: 10.183

7.  An AAV9 coding for frataxin clearly improved the symptoms and prolonged the life of Friedreich ataxia mouse models.

Authors:  Catherine Gérard; Xiao Xiao; Mohammed Filali; Zoé Coulombe; Marie Arsenault; Jacques Couet; Juan Li; Marie-Claude Drolet; Pierre Chapdelaine; Amina Chikh; Jacques P Tremblay
Journal:  Mol Ther Methods Clin Dev       Date:  2014-10-08       Impact factor: 6.698

8.  Genetic recombination events which position the Friedreich ataxia locus proximal to the D9S15/D9S5 linkage group on chromosome 9q.

Authors:  S Chamberlain; M Farrall; J Shaw; D Wilkes; J Carvajal; R Hillerman; K Doudney; A E Harding; R Williamson; G Sirugo
Journal:  Am J Hum Genet       Date:  1993-01       Impact factor: 11.025

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.